Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

Clin Mol Hepatol. 2023;29(1):168. Published online October 31, 2022

DOI: https://doi.org/10.3350/cmh.2022.0328

View: 2839 Download: 53 Web of Science: 1 Crossref: 1

So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2011;17(2):87-95. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.87

View: 13692 Download: 155 Crossref: 81

Kye Heui Lee , Ok Jae Lee , Young Chai Kim , Ran Namgung , Young Mo Sohn

Clin Mol Hepatol. 1997;3(1):58-64. Published online January 1, 1970

View: 2094 Download: 16

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5409	MAFLD: How is it different from NAFLD?
Viewed By 5220	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5098	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search